Biomarkers in gastroenterology: between hope and hype comes histopathology.

Abstract excerpt

Gastrointestinal cancers account for approximately 25% of all cancer deaths in the Western world. There is a need for a preventive strategy that can utilize biomarkers in order to stratify patients into appropriate screening or surveillance programs. Biomarkers are clinical variables associated with clinical outcomes. In cancer biology, the best biomarkers are germline adenomatous polyposis coli mutations, which...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biopsy, Needle
• Share to Esophageal Neoplasms
• Share to Gastrointestinal Neoplasms